These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
336 related articles for article (PubMed ID: 31768801)
1. Transition in the etiology of liver cirrhosis in Japan: a nationwide survey. Enomoto H; Ueno Y; Hiasa Y; Nishikawa H; Hige S; Takikawa Y; Taniai M; Ishikawa T; Yasui K; Takaki A; Takaguchi K; Ido A; Kurosaki M; Kanto T; Nishiguchi S; J Gastroenterol; 2020 Mar; 55(3):353-362. PubMed ID: 31768801 [TBL] [Abstract][Full Text] [Related]
2. The transition in the etiologies of hepatocellular carcinoma-complicated liver cirrhosis in a nationwide survey of Japan. Enomoto H; Ueno Y; Hiasa Y; Nishikawa H; Hige S; Takikawa Y; Taniai M; Ishikawa T; Yasui K; Takaki A; Takaguchi K; Ido A; Kurosaki M; Kanto T; Nishiguchi S; J Gastroenterol; 2021 Feb; 56(2):158-167. PubMed ID: 33219410 [TBL] [Abstract][Full Text] [Related]
3. Etiology of liver cirrhosis in Japan: a nationwide survey. Michitaka K; Nishiguchi S; Aoyagi Y; Hiasa Y; Tokumoto Y; Onji M; J Gastroenterol; 2010; 45(1):86-94. PubMed ID: 19789837 [TBL] [Abstract][Full Text] [Related]
4. Changes in Etiologies of Hospitalized Patients with Liver Cirrhosis in Beijing 302 Hospital from 2002 to 2013. Chang B; Li B; Sun Y; Teng G; Huang A; Li J; Zou Z Mediators Inflamm; 2017; 2017():5605981. PubMed ID: 29358850 [TBL] [Abstract][Full Text] [Related]
5. Etiological changes of liver cirrhosis and hepatocellular carcinoma-complicated liver cirrhosis in Japan: Updated nationwide survey from 2018 to 2021. Enomoto H; Akuta N; Hikita H; Suda G; Inoue J; Tamaki N; Ito K; Akahane T; Kawaoka T; Morishita A; Ogawa E; Tateishi R; Yoshiji H Hepatol Res; 2024 Aug; 54(8):763-772. PubMed ID: 38638067 [TBL] [Abstract][Full Text] [Related]
6. Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US veterans, 2001-2013. Beste LA; Leipertz SL; Green PK; Dominitz JA; Ross D; Ioannou GN Gastroenterology; 2015 Nov; 149(6):1471-1482.e5; quiz e17-8. PubMed ID: 26255044 [TBL] [Abstract][Full Text] [Related]
7. HBV infection is associated with greater mortality in hospitalised patients compared to HCV infection or alcoholic liver disease. Rajbhandari R; Danford CJ; Chung RT; Ananthakrishnan AN Aliment Pharmacol Ther; 2015 May; 41(10):928-38. PubMed ID: 25786514 [TBL] [Abstract][Full Text] [Related]
8. [Alcoholic liver diseases in Japan and modification by hepatitis virus]. Horie Y; Yamagishi Y; Ishii H Nihon Arukoru Yakubutsu Igakkai Zasshi; 2003 Oct; 38(5):403-14. PubMed ID: 14639919 [TBL] [Abstract][Full Text] [Related]
9. The burden of liver cirrhosis and underlying etiologies: results from the global burden of disease study 2017. Zhai M; Long J; Liu S; Liu C; Li L; Yang L; Li Y; Shu B Aging (Albany NY); 2021 Jan; 13(1):279-300. PubMed ID: 33436531 [TBL] [Abstract][Full Text] [Related]
11. Epidemiological and clinical scenario of chronic liver diseases in Italy: Data from a multicenter nationwide survey. Sagnelli E; Stroffolini T; Sagnelli C; Smedile A; Morisco F; Furlan C; Babudieri S; Brancaccio G; Coppola N; Gaeta GB; Almasio PL; Dig Liver Dis; 2016 Sep; 48(9):1066-71. PubMed ID: 27291331 [TBL] [Abstract][Full Text] [Related]
12. Non-alcoholic fatty liver disease is associated with greater risk of 30-day hospital readmission in the United States (U.S.). Paik JM; Eberly KE; Kabbara K; Harring M; Younossi Y; Henry L; Verma M; Younossi ZM Ann Hepatol; 2023; 28(4):101108. PubMed ID: 37088421 [TBL] [Abstract][Full Text] [Related]
13. Changes in the Global Burden of Chronic Liver Diseases From 2012 to 2017: The Growing Impact of NAFLD. Paik JM; Golabi P; Younossi Y; Mishra A; Younossi ZM Hepatology; 2020 Nov; 72(5):1605-1616. PubMed ID: 32043613 [TBL] [Abstract][Full Text] [Related]
14. Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology. Loria P; Marchesini G; Nascimbeni F; Ballestri S; Maurantonio M; Carubbi F; Ratziu V; Lonardo A Atherosclerosis; 2014 Jan; 232(1):99-109. PubMed ID: 24401223 [TBL] [Abstract][Full Text] [Related]
15. Addressing the global cirrhosis epidemic: one size will not fit all. Wang PL; Flemming JA Lancet Gastroenterol Hepatol; 2020 Mar; 5(3):230-231. PubMed ID: 31981522 [No Abstract] [Full Text] [Related]
16. National survey of hepatocellular carcinoma in heavy drinkers in Japan. Horie Y; Yamagishi Y; Kajihara M; Kato S; Ishii H Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):32S-36S. PubMed ID: 12960504 [TBL] [Abstract][Full Text] [Related]
17. Changing trends in the disease burden of primary liver cancer caused by specific etiologies in China. Liu Z; Mao X; Jiang Y; Cai N; Jin L; Zhang T; Chen X Cancer Med; 2019 Sep; 8(12):5787-5799. PubMed ID: 31385465 [TBL] [Abstract][Full Text] [Related]
18. Alcoholic liver disease confers a worse prognosis than HCV infection and non-alcoholic fatty liver disease among patients with cirrhosis: An observational study. Marot A; Henrion J; Knebel JF; Moreno C; Deltenre P PLoS One; 2017; 12(10):e0186715. PubMed ID: 29077714 [TBL] [Abstract][Full Text] [Related]
19. Temporal trends in prevalence of liver cancer and etiology-specific liver cancer from 1990 to 2019. Yang C; Jia J; Yu Y; Lu H; Zhang L Clin Res Hepatol Gastroenterol; 2024 Oct; 48(8):102451. PubMed ID: 39174005 [TBL] [Abstract][Full Text] [Related]
20. Changes in Characteristics of Patients with Liver Cirrhosis Visiting a Tertiary Hospital over 15 Years: a Retrospective Multi-Center Study in Korea. Jang WY; Chung WJ; Jang BK; Hwang JS; Lee HJ; Hwang MJ; Kweon YO; Tak WY; Park SY; Lee SH; Lee CH; Kim BS; Kim SH; Suh JI; Park JG J Korean Med Sci; 2020 Jul; 35(29):e233. PubMed ID: 32715667 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]